Question special

Can we extrapolate any of the data from RE-DUAL and PIONEER AF to use this strategy (P2Y12/NOAC) in patients that are at high risk for LV thrombus formation (large anterior MI) without afib. Alternatively, are there any ongoing studies looking to evaluate patients with recent PCI and need for anti-coagulation other than a-fib?